Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives

Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives

ABSTRACT Triple‐negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer, characterized by poor prognosis and limited therapeutic options. Although neoadjuvant chemotherapy (NACT) remains the established treatment approach, its suboptimal efficacy associated with TNBC highlight...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenjun Huang, Qing Peng, Luhui Mao, Wenhao Ouyang, Yunjing Xiong, Yujie Tan, Haizhu Chen, Zebang Zhang, Tang Li, Yuanjia Hu, Ying Wang, Wei Zhang, Herui Yao, Yunfang Yu
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:MedComm – Future Medicine
Subjects:
future perspectives
immunotherapy
neoadjuvant chemotherapy
platinum‐based agents
targeted therapy
triple‐negative breast cancer
Online Access:https://doi.org/10.1002/mef2.70013
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/mef2.70013

Similar Items